| Date & Time | 23-24 February 2027 |
|---|---|
| Location | Virtual Conference |
Extrachromosomal DNA (ecDNA) has emerged as a major driving force in cancer, promoting intratumoral genetic heterogeneity, elevated oncogene copy number, rapid tumour evolution, and treatment resistance, all resulting in shorter survival for patients with many different types of cancer.
ecDNA is a genetic, epigenetic, and immunological problem, changing how oncogenes, immunomodulatory genes, and gene regulatory elements are inherited and how they function. Recent recognition of ecDNA’s enabling role as a hallmark of cancer – particularly as it results from and promotes genome instability – has highlighted the critical need to better understand its underlying biology.
Advances in the field are happening rapidly, and this first EACR virtual conference on the topic will address some of the most recent science that promises to transform our understanding of cancer and translate into benefit for patients.
The target audience for this conference is basic and translational scientists and clinicians, senior and young investigators. We welcome and encourage not only scientists currently studying ecDNA, but those interested in learning more about and contributing to the field.
Deadlines:
- Abstract submission deadline: 14 January 2027
- Registration deadline: 08 February 2027
